# Actinium Pharmaceuticals, Inc.: Form 8-K, filed Dec 1, 2023

- Company: [Actinium Pharmaceuticals, Inc.](/companies/atnm.md) (CIK 1388320)
- Form: 8-K
- Filed: 2023-12-01
- Accepted by EDGAR: Dec 1, 2023, 22:00 ET
- Period: 2023-11-30
- Accession: 0001213900-23-092089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/ea189365-8k_actinium.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/ea189365-8k_actinium.htm

Filed Dec 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-092089. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.
